Entity

Aptadel Therapeutics

Biotechnology - Therapeutics and Diagnostics

 

Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology. Aptadel’s lead indication is Ewing Sarcoma, a rare variety of cancer affecting children.

glorente@aptadeltx.com

aptadeltx.com


Contact person: Gisela Lorente

Location: Ed. Clúster - 02D83bis